Abbott-backed medical firm Domesco to pay 25% cash dividend

Domesco Medical Import Export JSC (HoSE: DMC) will distribute a 25% cash dividend for 2024, equivalent to VND2,500 (9.5 U.S. cents) per share.

With more than 34.7 million outstanding shares, the payout, scheduled for October 16, is esimated at VND87 billion ($3.3 million).

Major shareholders are set to benefit significantly. Abbott Laboratories (Chile) Holdco Spa, a subsidiary of U.S.-based Abbott Laboratories and Domesco’s largest shareholder with a 51.69% stake, will receive about VND45 billion ($1.7 million).

The government-owned State Capital Investment Corp (SCIC), which holds a 34.71% stake, will receive more than VND30 billion ($1.14 million).

In the first half of 2025, Domesco reported revenue of VND979 billion ($30.2 million), up over 11% year-on-year, but net profit fell over 15% to nearly VND79 billion ($3 million).

The company attributed revenue growth to stronger branding efforts, promotional sales strategies, and expanded distribution channels. However, higher import costs from a stronger exchange rate, rising logistics expenses, and tighter supplies of pharmaceutical raw materials pushed up costs and weighed on profit.

Founded in 1989, Domesco specializes in the research, development, production and marketing of pharmaceuticals, herbal medicines, dietary supplements, and medical supplies.